Abstract:OBJECTIVE:To explore the circadian blood pressure (BP) profile and its influencing factors in essential hypertensive patients after treatment. METHODS:Cross-sectional surveillance was carried out in essential hypertensive subjects after treatment whose clinic blood pressure had been under control as 140/90 mm Hg (1 mm Hg = 0.133 kPa) for at least one month. All patients underwent a twenty-four-hour ambulatory blood pressure monitoring device (spacelabs 90207). The nocturnal fall of blood pressure (BP) was calculated from (daytime mean BP-night-time mean BP)/daytime BP, while 'daytime' values were recorded between 6 h and 22 h and 'night-time' values between 22 h and 6 h. Non-dippers were defined as those whose nocturnal decrease in mean systolic BP and/or mean diastolic BP was < 10% of the daytime BP. Binary logistic regression analysis was used to evaluate the correlation between circadian blood pressure profile and factors as gender, age, height, body mass index (BMI), family history of premature cardiovascular disease, women under age 65 or men under age 55, smoking habits, grade of hypertension, and strategy of antihypertensive drugs. RESULTS:208 treated essential hypertensive patients were enrolled in the study. 79 individuals were dippers and 129 were non-dippers. Data from logistic regression analysis showed that four factors as age, premature family history of cardiovascular disease, overweight or obesity, and strategy of antihypertensive drugs were significantly influencing the circadian blood pressure profile in treated hypertensive patients. The incidence of non-dippers in patients of 70 years of age or older and those between 60 and 69 were 3.3 and 2.3 times of those with less than 60 (P = 0.009 and 0.031, respectively). The prevalence of non-dippers in patients with a premature family history of cardiovascular disease was 3.7 times greater than those in subjects without a premature history of cardiovascular disease (P = 0.029). Similarly, the incidence of non-dippers in patients of overweight (24 = BMI < 28) and obesity (BMI >/= 28) were 3.0 and 4.8 times of those in subjects of normal weight (P = 0.003 and 0.009, respectively). Compared with patients treated with long-acting calcium channel blockers (CCBs), patients treated with angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs) alone had less prevalence of nondippers (OR = 0.139, P = 0.010). Patients treated with joint antihypertensive scheme including ACE inhibitors or ARBs(but not including diuretics) had the tendency of lower incidence of abnormal circadian blood pressure rhythm (OR = 0.453, P = 0.118). Patients treated with joint antihypertensive scheme including diuretics (not including ACE inhibitors or ARBs) and with joint antihypertensive strategy including diuretics and ACE inhibitors or ARBs had lower incidence of nondippers (OR = 0.378 and 0.273, respectively; P = 0.030 and 0.011, respectively). CONCLUSIONS:Approximately 2/3 treated essential hypertensive patients had a non-dipper blood pressure profile. Age, premature family history of cardiovascular disease, overweight/obesity, and antihypertensive drugs strategy were correlated with circadian blood pressure profile. Compared with long-acting CCBs, diuretics, ACE inhibitors or ARBs might be helpful in keeping the circadian blood pressure rhythm at normal range.

Application of Nocturnal decreasing index in evaluation of antihypertensive agents

Analysis of trough:peak ratio and smoothness index calculated by different methods in chlinical evaluation of long-gffective antihypertensive agents

Differential Effects of Morning or Evening Dosing of Amlodipine on Circadian Blood Pressure and Heart Rate

Evaluation of Efficacy of Atenolol and Diltiazem-Sr in the Treatment of Hypertension

PS-C31-2: PRELIMINARY STUDY OF ANTIHYPERTENSIVE TREATMENT EFFECT ON EARLY EVENING ELEVATED BLOOD PRESSURE

Effects of Compound Hypotensive Tablets Administered at Different Time Points on Pressure Rhythm and 24-Hour Ambulatory Blood Pressure in Patients with Non-dipper Essential Hypertension

Study of the effects on blood pressure for patients with patients with non-dipper hypertension by different administration time

Evening dosing versus morning dosing of antihypertensive medications for nocturnal hypertension: a systematic review and meta-analysis of 107 randomized controlled trials

Abstract 13243: Different Efficacy of Angiotensin Receptor Blockers for Nocturnal Blood Pressure Reduction in Patients with Mild to Moderate Hypertension: A Systematic Review and Meta-Analysis

Effect of optimized administration time of amlodipine besylate tablets on the morning blood pressure surge in elderly hypertensive patients

Captopril Administered at Night Restores the Diurnal Blood Pessure Rhythm in Adequately Controlled, Nondipping Hypertensives

Profile on Circadian Blood Pressure and the Influencing Factors in Essential Hypertensive Patients after Treatment

A18207 Effect of Nifedipine Controlled Released Tablets (xinran) on Home Morning Blood Pressure in Mild-to-moderate Hypertension

Blood Pressure Lowering Efficacy Of Amlodipine And Nifedipine-Gits In Ambulatory Hypertension

Effect Of Nifedipine Controlled Released Tablets (Xinran) On Home Morning Blood Pressure In Mild-To-Moderate Hypertension: A Multicenter, Randomized, Active-Controlled Clinical Trial In China

Current Status of Morning Blood Pressure Control and Medication of Hypertensive Patients in Beijing

The Efficacy of Nebivolol on Patient with Mild or Moderate Mssential Hypertension by Different Smbulatory Blood Pressure Monitoring Methods

Using Different Methods to Evaluate the Efficacy of Olmesartan Medoxomil in Chinese Patients with Mild to Moderate Essential Hypertension According to Ambulatory Blood Pressure Monitoring

Evaluation of the Effects of Nifedipine GITS on the Blood Pressure Parameters in Subacute Cerebral Infarction with Essential Hypertension by Ambulatory Blood Pressure Monitoring

Comparison of Beijing Anti-hypertension 0 and Amlodiping in Treatment Essential Hypertension

Twenty-four-hour Ambulatory Blood Pressure Changes in Older Patients with Essential Hypertension Receiving Monotherapy or Dual Combination Antihypertensive Drug Therapy.